Hospital stocks fall as SC questions drug mark-ups
Shares of major hospital chains, including Apollo Hospitals and Fortis Healthcare, fell up to 6% after the Supreme Court questioned steep drug mark-ups. The court highlighted a tenfold price difference for a cancer drug, urging the Centre to consider a uniform 16% margin on all medicines. This scrutiny could lead to regulatory changes impacting hospital pricing practices.